Bayer AG struck a $2 billion deal on Wednesday to resolve a category motion of future claims referring to allegations that its extensively used weedkiller Roundup causes most cancers, in accordance with U.S. attorneys.
www.nasdaq.com
Bayer reaches $2 bln deal over future Roundup claims
